Zeke Capital Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $26.3K | Hold |
|
|||||
|
2022
Q3 | $36K | Hold |
|
|||||
|
2022
Q2 | $57K | Hold |
|
|||||
|
2022
Q1 | $102K | Hold |
|
|||||
|
2021
Q4 | $143K | Hold |
|
|||||
|
2021
Q3 | $211K | Hold |
|
|||||
|
2021
Q2 | $263K | Hold |
|
|||||
|
2021
Q1 | $231K | Hold |
|
|||||
|
2020
Q4 | $164K | Hold |
|
|||||
|
2020
Q3 | $165K | Sell |
|
|||||
|
2020
Q2 | $1.49M | Buy |
|
|||||
|
2020
Q1 | $1.54M | Hold |
|
|||||
|
2019
Q4 | $2.43M | Hold |
|
|||||
|
2019
Q3 | $3.04M | Sell |
|
|||||
|
2019
Q2 | $5.57M | Buy |
|
|||||
|
2019
Q1 | $128K | Hold |
|
|||||
|
2018
Q4 | $70K | Hold |
|
|||||
|
2018
Q3 | $193K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $114K | Buy |
|